Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Fosamax (alendronate sodium) Tablets
Company:  Merck Research Laboratories
Application No.:  020560, S18
Approval Date: 11/24/1999


Date created: April 24, 2003

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.